Categories: Health

HUTCHMED to Announce 2025 Half-Year Financial Results

 | Source: HUTCHMED (China) Limited

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).

HUTCHMED management will host two webcast presentations for analysts and investors to discuss the interim results, followed by Q&A sessions. The English webcast will be held on Thursday, August 7, 2025, at 8:00 am EDT (1:00 pm BST / 8:00 pm HKT). The Chinese (Putonghua) webcast will be held at 8:30 am HKT / 1:30 am BST on Friday, August 8, 2025 (8:30 pm EDT on Thursday, August 7, 2025).

Both webcasts will be available live via the company website at www.hutch-med.com/event/. The presentation will be available to download shortly before the webcast begins. A replay will also be available on the website shortly after the event.

About HUTCHMED

HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

CONTACTS

Investor Enquiries +852 2121 8200 / ir@hutch-med.com
Media Enquiries
FTI Consulting – +44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Alex Shaw +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile)
Brunswick – Zhou Yi +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Panmure Liberum Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden +44 20 7886 2500
Cavendish Joint Broker
Geoff Nash / Nigel Birks +44 20 7220 0500
Deutsche Numis Joint Broker
Freddie Barnfield / Jeffrey Wong / Duncan Monteith +44 20 7260 1000
GlobeNews Wire

Recent Posts

Instinct Science Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies

August 14, 2025 12:37 ET  | Source: Instinct Science PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE)…

7 hours ago

Tecan issues CHF 150 million straight bond

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES…

7 hours ago

Bigg Boss 19: Fans to choose Shehbaz Badesha or Mridul Tiwari as one of the contestants

Bigg Boss 19 on JioHotstar Goes ‘Democrazy’: Fans to choose Shehbaz Badesha or Mridul Tiwari…

8 hours ago

Parallels Named a Visionary in 2025 Gartner Magic Quadrant for Desktop as a Service for Second Year in a Row

AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Parallels, a global leader in virtualization and…

8 hours ago

Kahuna Expands Customer Integration Support with Strategic eSkillz Partnership

HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Kahuna Workforce Solutions, a leading skills and competency…

8 hours ago

Angel Reese and Reebok Reveal Release Date of Her FirstEver Signature Shoe, The Angel Reese 1 Available September 18, 2025

Debuting in Three Distinct Colorways, the Angel Reese 1 is Built for the Court and…

10 hours ago